THREAD Launches New AI Tools to Derive Patient Insights For Research Design and Retention
Decentralized Research Provider Launches Enhanced GPT-Powered inVibe Features to Automate Patient Insight Generation
CARY, N.C., 28 MAR 2023 – THREAD®, a leading decentralized research, eCOA and consulting services provider, announced today that it has launched the newest artificial intelligence (AI) tools to further automate patient insight generation for customers. The provider has launched enhanced GPT-powered features within its inVibe voice data capture solution to accelerate data-generated insights that support research design, patient recruitment and retention.
Since joining OpenAI’s API Beta program in early 2021, THREAD’s inVibe solution has developed algorithms utilizing GPT. Building on this multi-year experience with GPT-3, it has engaged these new features to expand opportunities for sponsors and contract research organizations (CROs) to leverage AI when analyzing patient voice data. Customers can now interact directly with the AI in the platform to ask complex questions about their data and receive unique insight summaries by:
- Utilizing the “Smart Summary” feature to receive an immediate AI-powered response offering a draft write-up of data insights
- Engaging with the “Playground” feature to interact in real-time with the AI in exploring the dataset for patient insights
- Obtaining enhanced sentiment analysis solutions via new automations
“Our enhanced use of AI and the newest software tools helps our customers more efficiently review data to support their research efforts,” said John Reites, co-founder and CEO, THREAD. “These new AI-assisted features enable us to more rapidly generate insights from complex datasets that provide value for research design, patient recruitment and engagement.”
THREAD’s® purpose is to leverage its decentralized research platform to enable studies for everyone, everywhere. The company’s uniquely combined clinical research technology and consulting services help biopharma and CROs to design, operate, and scale next-generation research studies and electronic clinical outcome assessments (eCOA) programs for participants, sites, and study teams. Through its comprehensive platform and scientific expertise, THREAD empowers studies to be accessible, efficient, and centered on the patient. Backed by health care investors Water Street Healthcare Partners and JLL Partners, THREAD is recognized as a leader by Everest Group’s Decentralized Clinical Trial Product PEAK Matrix® Assessment 2021/2022 and positioned in the Leader's Category of the 2022 IDC MarketScape for R&D Decentralized Clinical Trial Technology Solutions Vendor Assessment 2022. Visit THREADresearch.com to learn more.